Keywords: pfizer, exits, biobypass, deal, genvec, decided, continue

Pfizer exits BioBypass deal with GenVec

Article | 04 February 2002

Print This

Pfizer has decided not to continue its collaboration with GenVec onBioBypass, which is now in Phase II trials for coronary ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in